Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years

被引：0
|
作者：
Horinouchi, H. [1 ]
Ohe, Y. [1 ]
Yamanaka, Y. [2 ]
Kurata, T. [2 ]
Watanabe, K. [3 ]
Hosomi, Y. [3 ]
Nakahara, Y. [4 ]
Asao, T. [5 ]
Saeki, S. [6 ]
Tsubata, Y. [7 ]
Fujita, Y. [8 ]
Konishi, J. S. [9 ]
Mizugaki, H. [10 ]
Ohuchi, M. [11 ]
Yagishita, S. [11 ]
Hamada, A. [11 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Kansai Med Univ Hosp, Osaka, Japan
[3] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[4] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan
[5] Juntendo Univ Hosp, Tokyo, Japan
[6] Kumamoto Univ Hosp, Kumamoto, Japan
[7] Shimane Univ, Fac Med, Matsue, Shimane, Japan
[8] Jikei Univ, Sch Med, Tokyo, Japan
[9] Hokkaido Univ, Fac Med, Sapporo, Hokkaido, Japan
[10] JFCR, Canc Inst Hosp, Tokyo, Japan
[11] Natl Canc Ctr, Res Inst, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Pembrolizumab; pharmacokinetics; Elderly;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-08
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [31] PULMONARY RESECTION IN PATIENTS AGED 80 YEARS OR OVER WITH NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE SURVEY OF 602 CASES IN A JAPANESE JOINT COMMITTEE FOR LUNG CANCER REGISTRATION STUDY
    Okami, Jiro
    Higashiyama, Masahiko
    Sawabata, Noriyoshi
    Miyaoka, Etsuo
    Asamura, Hisao
    Nakanishi, Yoichi
    Eguchi, Kenji
    Mori, Masaki
    Nomori, Hiroaki
    Fujii, Yoshitaka
    Okumura, Meinoshin
    Yokoi, Kohei
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S650 - S650
  • [32] Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study
    Benguerfi, Soraya
    Lesimple, Thierry
    Houot, Roch
    Ricordel, Charles
    Legoupil, Delphine
    Alleaume, Corinne
    Lamy, Regine
    Lagadec, Delphine Deniel
    Corre, Romain
    ACTA ONCOLOGICA, 2022, 61 (11) : 1339 - 1346
  • [33] Clinical benefit of platinum doublet combination therapy in older adults with advanced non-small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan
    Shimokawa, Mototsugu
    Kanazu, Masaki
    Saito, Ryusei
    Mori, Masahide
    Tamura, Atsuhisa
    Okano, Yoshio
    Fujita, Yuka
    Endo, Takeo
    Motegi, Mitsuru
    Takata, Shohei
    Kita, Toshiyuki
    Sukoh, Noriaki
    Mizuki, Fumitaka
    Takenoyama, Mitsuhiro
    Atagi, Shinji
    THORACIC CANCER, 2023, 14 (17) : 1597 - 1605
  • [34] Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis
    Miriam Blasi
    Martin E. Eichhorn
    Petros Christopoulos
    Hauke Winter
    Claus Peter Heußel
    Felix J. Herth
    Rami El Shafie
    Katharina Kriegsmann
    Mark Kriegsmann
    Albrecht Stenzinger
    Helge Bischoff
    Michael Thomas
    Jonas Kuon
    BMC Pulmonary Medicine, 22
  • [35] Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer
    Shu, Zekai
    Dong, Baiqiang
    Shi, Lei
    Shen, Wei
    Hang, Qingqing
    Wang, Jin
    Chen, Yuanyuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (05) : 1263 - 1271
  • [36] Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer
    Zekai Shu
    Baiqiang Dong
    Lei Shi
    Wei Shen
    Qingqing Hang
    Jin Wang
    Yuanyuan Chen
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1263 - 1271
  • [37] Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab
    Hitomi Jo
    Tatsuya Yoshida
    Hidehito Horinouchi
    Shigehiro Yagishita
    Yuji Matsumoto
    Yuki Shinno
    Yusuke Okuma
    Yasushi Goto
    Noboru Yamamoto
    Kazuhisa Takahashi
    Noriko Motoi
    Yuichiro Ohe
    Cancer Immunology, Immunotherapy, 2022, 71 : 387 - 398
  • [38] Efficacy of pembrolizumab combined with anlotinib in 3 patients with advanced non-small cell lung cancer
    Zhu, Haoshuai
    Zeng, Bo
    Zou, Jianyong
    Su, Chunhua
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42
  • [39] Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab
    Jo, Hitomi
    Yoshida, Tatsuya
    Horinouchi, Hidehito
    Yagishita, Shigehiro
    Matsumoto, Yuji
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Yamamoto, Noboru
    Takahashi, Kazuhisa
    Motoi, Noriko
    Ohe, Yuichiro
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (02) : 387 - 398
  • [40] Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer
    Leshem, Yasmin
    Dolev, Yardenna
    Siegelmann-Danieli, Nava
    Moser, Sarah Sharman
    Apter, Lior
    Chodick, Gabriel
    Nikolaevski-Berlin, Alla
    Shamai, Sivan
    Merimsky, Ofer
    Wolf, Ido
    CANCER, 2023, 129 (18) : 2789 - 2797
12345